Biomedical Advanced Research and Development Authority (BARDA)

214 articles about Biomedical Advanced Research and Development Authority (BARDA)

• Biomedical Advanced Research and Development Authority (BARDA) Release: HHS Awards $17 Million for Patient-Centered Outcomes Research

  9/2/2010

• Cellerant Therapeutics, Inc. Awarded $153 Million Contract by Biomedical Advanced Research and Development Authority (BARDA) to Develop Treatment for Acute Radiation Syndrome (ARS)

  9/1/2010

• ImmuneRegen BioSciences, Inc. Invited to Submit Full Proposal to Biomedical Advanced Research and Development Authority (BARDA) for Homspera(R) as a Potential Medical Countermeasure for Injury Associated With Radiation Exposure

  8/31/2010

• Achaogen Awarded Contract Worth up to $64 Million by Biomedical Advanced Research and Development Authority (BARDA) for the Development of ACHN-490

  8/31/2010

• Biomedical Advanced Research and Development Authority (BARDA) Funds Drug Development for Biothreats, Antibiotic Resistance

  8/30/2010

• Biomedical Advanced Research and Development Authority (BARDA) Exercises $4.1 Million Fourth Option on Cleveland Biolabs Inc. Contract to Develop Radiation Countermeasure CBLB502

  7/29/2010

• Biomedical Advanced Research and Development Authority (BARDA) Exercises Options on Cleveland Biolabs Inc. $15.6 Million Contract to Develop Radiation Countermeasure CBLB502

  4/29/2010

• Aeolus Pharmaceuticals Inc. Invited to Submit Full Proposal to Biomedical Advanced Research and Development Authority (BARDA) for AEOL 10150 as a Potential Medical Countermeasure for Pulmonary Injury Associated with Acute Radiation Syndrome and Delayed Ef

  1/12/2010

• Biomedical Advanced Research and Development Authority (BARDA) Awards Elusys Therapeutics, Inc. up to $143 Million for Advanced Development of a New Drug to Treat Anthrax

  12/28/2009

• Biomedical Advanced Research and Development Authority (BARDA) Awards Contracts for Tests and Devices to Help the Nation Respond to a Radiological Emergency

  12/18/2009

• Cleveland Biolabs Inc. Receives $2.3 Million Addition to $13.3 Million Contract With Biomedical Advanced Research and Development Authority (BARDA) to Develop Radiation Countermeasure Protectan CBLB502

  9/24/2009

• Aeolus Pharmaceuticals Inc. Submits White Paper to Biomedical Advanced Research and Development Authority (BARDA) for Funding of AEOL 10150 as a Countermeasure to Lung Injury Due to Radiation Exposure

  9/11/2009

• Cellerant Therapeutics, Inc. Awarded $13.5 Million Contract for Treatment of Acute Radiation Syndrome from the Biomedical Advanced Research and Development Authority (BARDA)

  9/22/2008

• Neumedicines Inc. Awarded BAA-BARDA-08-08 Contract by the Biomedical Advanced Research and Development Authority (BARDA)

  9/19/2008